Are there high-quality evidences supporting the use of 100mg/day aspirin to improve vascular dementia?
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901726434426880 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The evidence does not support the use of 100 mg/day aspirin for the prevention or improvement of vascular dementia, with studies indicating no cognitive benefits and potential harm. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17895902 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Are there high-quality evidences supporting the use of 100mg/day aspirin to improve vascular dementia? Tripdatabase vascular dementia aspirin AAS evidence neurology pharmacology dementia treatment long-term management vascular cognitive impairment The evidence does not support the use of 100 mg/day aspirin for the prevention or improvement of vascular dementia, with studies indicating no cognitive benefits and potential harm. |
| title | Are there high-quality evidences supporting the use of 100mg/day aspirin to improve vascular dementia? |
| topic | vascular dementia aspirin AAS evidence neurology pharmacology dementia treatment long-term management vascular cognitive impairment |
| url | https://doi.org/10.5281/zenodo.17895902 |